FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 3210373 · Received July 8, 2013

Report

Report Number
2124215-2013-06992
Event Type
Injury
Date Received
July 8, 2013
Date of Event
April 19, 2013
Report Date
April 19, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT ONE DAY POST IMPLANT, FOLLOW UP REVEALED THIS RIGHT VENTRICULAR LEAD AND DEVICE WERE NOT PACING OR MEASURING R-WAVES, IMPEDANCE OR CHECKING THRESHOLDS. AN ELECTROGRAM WAS PROVIDED TO AN INTERNAL TECHNICAL SERVICE(TS) CONSULTANT FOR THEIR REVIEW. TS REVIEWED THE DATA AND RECOMMENDED VERIFYING THE LEAD POSITION. A REVISION PROCEDURE WAS PERFORMED. UPON REOPENING THE POCKET, THE LEAD PARAMETERS WERE VERIFIED. VISUAL OBSERVATION REVEALED A LEAD CONNECTION. THE LEAD WAS REMOVED AND REINSERTED INTO THE LEAD BARREL AND NORMAL PACING WAS OBSERVED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
309800 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4457

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R